NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10 | 0.0% | 101 | 0.0% | 0.01% | +16.7% |
| Q2 2023 | $10 | +11.1% | 101 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $9 | 0.0% | 101 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $9 | -99.9% | 101 | +9.8% | 0.01% | 0.0% |
| Q2 2022 | $8,000 | -61.9% | 92 | -64.8% | 0.01% | -60.0% |
| Q3 2021 | $21,000 | -12.5% | 261 | 0.0% | 0.02% | -11.8% |
| Q2 2021 | $24,000 | +9.1% | 261 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $22,000 | -12.0% | 261 | 0.0% | 0.02% | -15.0% |
| Q4 2020 | $25,000 | +8.7% | 261 | 0.0% | 0.02% | 0.0% |
| Q3 2020 | $23,000 | 0.0% | 261 | 0.0% | 0.02% | +5.3% |
| Q2 2020 | $23,000 | +4.5% | 261 | 0.0% | 0.02% | -13.6% |
| Q1 2020 | $22,000 | -31.2% | 261 | -23.2% | 0.02% | -12.0% |
| Q4 2019 | $32,000 | +6.7% | 340 | 0.0% | 0.02% | +4.2% |
| Q3 2019 | $30,000 | +328.6% | 340 | +330.4% | 0.02% | +300.0% |
| Q2 2019 | $7,000 | -12.5% | 79 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $8,000 | – | 79 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |